March 2008

Global Opportunities

March 2, 2008

According to Ernst & Young, the sheer volume and growing economic muscle of consumers in emerging markets provide powerful investment incentives for multinational companies (MNCs). In particular, current and projected growth rates for pharmaceutical markets in the BRIC countries and Mexico exceed those in the more mature markets in the United States, Europe, and Japan. […]

Last Word

March 2, 2008

Alan C. Moses, M.D., is VP, Chief Medical Officer Worldwide, Novo Nordisk Inc. He has a broad and indepth background in diabetes research and specialization. Previously, Dr. Moses was Senior VP and Chief Medical Officer at the Joslin Diabetes Center and joined Novo Nordisk in April 2004 as Associate VP of Medical Affairs and since […]

Talent Pool

March 2, 2008

Pharma POOL Wendy KOUBA Wyeth Names Communications VP Wyeth, Madison, N.J., has promoted Wendy Kouba to VP, cor porate communications, from VP, communica tions, technical operations and product supply. In this new role, Ms. Kouba oversees the company’s global public relations and communications functions, including issues management, media relations, product publicity, internal communications, community relations, […]

On the Calendar

March 2, 2008

March 1718 3rd Imaging in Preclinical &Clinical Drug Development San Diego For more information, contact Vivian Frankel, GTCBio, at 6262566405, email vivian.frankel@gtcbio.com, or visit gtcbio.com. March 1718 The Inaugural U.S.Conference on Comparator Studies Doubletree Hotel,Philadelphia For more information, contact Andrea Chadis, Center for Business Intelligence, at 7819392428, email a.chadis@cbinet.com, or visit cbinet.com. March 1718 Pharmaceutical […]

E-Media

March 2, 2008

NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Edge Dynamics has added a flexible desktop module within its Demand Management Suite that offers lifesciences manufacturers a way to easily monitor and analyze channel activity data for their products. The Edge Dynamics Demand Dashboard interface allows individuals across the enterprise to quickly answer the most crit […]

What’s New

March 2, 2008

WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES HealthEd Group has launched HealthEd Encore, which operates as a standalone agency, in response to increas ing client demand for educational patient marketing campaigns. HealthEd Encore offers a fullrange of ser vices, including consumer/patient product education, Website development, treatment adherence programs and provider/patient dialogue support.Similar to HealthEd, […]

PharmaTrax

March 2, 2008

Best practices in planning and targeting and conducting office calls, as well as management of relationships, samples, programs, and salesforces are explored. These include the use of automated for mulary data and thoughtleader information to develop sales messages that anticipate formulary restrictions and opportunities,and the integration of activity triggers into annual planning calendars to prepare […]

For Art’s Sake

March 2, 2008

There have been more than a few occasions when I felt I needed nothing short of a magic spell to get a client to run with an unconventional concept — the one that’s wonderfully unique while completely hitting the mark. The team at GSWWorldwide has done just that with their new “Itchcraft”campaign for Protopic. They’ve […]

PharmaOutlet

March 2, 2008

Research collaborations can be a very useful adjunct to a company’s scientific investigations. They can expand their intellectual property portfolios, speed up the entry of molecules into the clinic, and possibly enhance their future revenue streams. In fact, there may be times when your company’s research efforts will require a collaboration with another scientist to […]

The Fourth Tier: Tighter Control of Specialty Drugs

March 2, 2008

Managed MARKETS Managed care organizations are tackling the rising costs and expanding use of specialty products. Specialty drugs, injectable biologics, and other highercost drugs that require close supervision and monitoring are the fastest growing segment of the overall pharmaceutical space. The average annual increase in drug cost expenditures reported in 2007 was 6.9%,accord ing to […]

A Strategy for Pharma Diversification

March 2, 2008

In response to myriad challenges and with the hope of renewing double digit growth, the question becomes whether pharmaceutical firms should hold on to a pure pharmaceutical business model or embrace a more aggressive diversification strategy, says Roger Fournier, a senior executive working at a global pharmaceutical company. Some companies are reducing the breadth of […]

Ted Schroeder — A Thoughtful Note

March 2, 2008

BY KIM RIBBINK A THOUGHTFUL ote considered approach to leadership has helped Ted Schroeder guide his team through ups and downs and set Cadence Pharmaceuticals on a defined path, one in which a vibrant culture and strong core values are the keys to its longterm success. N A A Photography by nathanpetty.com PV0308 LAYOUT 2/14/08 […]

A Woman’s Heart

March 2, 2008

Women are six times more likely to die from heart attacks than breast cancer. Car diovascular diseases (CVD), particularly coronary heart disease (CHD) and stroke, remain the leading causes of death of women in America and most developed coun tries, with almost 39% of all female deaths in the United States occurring from CVD. Yet […]

Climbing the Corporate Lattice

March 2, 2008

BY KIM RIBBINK executive search firm. “People need to be more prepared to work in a number of different companies or settings, including not just pharma but also specialty pharma and startup biotech.” This means there is tremendous movement in the industry, which presents challenges for companies hiring individuals as well as for employees developing […]

User Fees: Devising a Shift in Policy

March 2, 2008

BY DENISE MYSHKO New laws and regulations aimed at improving reviews of medical devices have been put in place. In September 2007, President George W. Bush signed a broadranging bill that expands the regulatory authority of the Food and Drug Administration. Combined with the legislation were sever al bills that had been pending for some […]

Strengthening the Clinical Recruitment Chain

February 26, 2008

W finding the right population within the right time frame means doing your homework, looking at feasibility data, modeling time frames, metrics, and budget parameters.” Negative press is another uncontrollable factor that can slow patient enrollment, par ticularly if a drug is pulled from the market because of an adverse event and the clinical study […]

UpFront

February 26, 2008

DETAILING DUDS Rep Access Continues to Fall Based on a comprehensive telephone survey of 180,000 doctors, almost one fifth of U.S. officebased physicians refuse to see sales representatives from the drug and device industry at any time, according to SK&A Information Services. Another 22.7% of doctors require the sales representatives to set an appointment. These […]

Letter from the Editor

February 26, 2008

It may not be Jules Verne’s rendition of “Around the World in 80 days,” but for many pharmaceutical company managers it’s time to brush up on their language skills and make sure their passports are in order. The world is definitely getting smaller. Companies that were once aligned as being multinational are changing to global. […]

FEEDBACK